Cardinal Health Reports Q1 FY2027 Results and Raises Full-Year Non-GAAP EPS Guidance
Cardinal Health reported first-quarter fiscal 2027 revenue of $67.5 billion, a 5% increase year-over-year, alongside a GAAP diluted EPS of $2.38. Driven by strong segment performance, the company raised its full-year non-GAAP diluted EPS guidance range to $12.80 to $13.00 and completed a $500 million share repurchase program.
Key points
- First-quarter revenue increased 5% to $67.5 billion compared to the prior-year period.
- GAAP diluted EPS grew 27% to $2.38 and non-GAAP diluted EPS grew 28% to $3.26.
- Fiscal year 2027 non-GAAP EPS guidance was raised to a range of $12.80 to $13.00.
- The company completed its $500 million share repurchase program during the first quarter.
The filing
Written by AI (Google Gemini, gemini-3.5-flash-lite) on Nov 5, 2026, 8:16 AM ET, from the text of the filing and its press-release exhibits only.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.